Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbo...
Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The global spread of Zika virus (ZIKV) and its unexpected association with congenital defects necessitates the rapid development of a safe and effective vaccine. Here we report the development and characterization of a recombinant chimeric ZIKV vaccine candidate (termed ChinZIKV) that expresses the prM-E proteins of ZIKV using the licensed Japanese...
Alternative Titles
Full title
Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_788df413c3c54bebaab8d4b979a10833
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_788df413c3c54bebaab8d4b979a10833
Other Identifiers
ISSN
2041-1723
E-ISSN
2041-1723
DOI
10.1038/s41467-018-02975-w
